Evidence map›Paper›PMID 33827830›Full record

ArticleBMJ open2021

Prevalence and coprevalence of modifiable risk factors for upper digestive tract cancer among residents aged 40-69 years in Yangzhong city, China: a cross-sectional study.

Xiang Feng, Zhao-Lai Hua, Qin Zhou, Ai-Wu Shi, Tong-Qiu Song, Dong-Fu Qian, Ru Chen, Gui-Qi Wang, Wen-Qiang Wei, Jin-Yi Zhou and 3 more

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 1 country.

Xiang FengInstitute of tumour prevention and control, People's Hospital of Yangzhong City, Yangzhong, China.ORCID 0000-0001-8997-6381
Zhao-Lai HuaInstitute of tumour prevention and control, People's Hospital of Yangzhong City, Yangzhong, China 75545075@qq.com.
Qin ZhouInstitute of tumour prevention and control, People's Hospital of Yangzhong City, Yangzhong, China.
Ai-Wu ShiInstitute of tumour prevention and control, People's Hospital of Yangzhong City, Yangzhong, China.
Tong-Qiu SongInstitute of tumour prevention and control, People's Hospital of Yangzhong City, Yangzhong, China.
Dong-Fu QianSchool of Health Policy & Management, Nanjing Medical University, Nanjing, China.
Ru ChenNational Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Cancer Registry Office, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Gui-Qi WangNational Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Cancer Registry Office, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Wen-Qiang WeiNational Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Cancer Registry Office, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Jin-Yi ZhouDepatment of Non-communicable Disease Prevention, Jiangsu Province Center for Disease Control and Prevention, Nanjing, China.
Jie-Jun WangChangzheng Hospital, Department of Oncology, Second Military Medical University, Shanghai, China.
Gang ShaoDepartment of Oncology, 923rd Hospital of PLA, Hangzhou, China.ORCID 0000-0003-1068-6790
Xi WangDepartment of Oncology, 923rd Hospital of PLA, Hangzhou, China.
People's Hospital of Yangzhong · CNChinese Academy of Medical Sciences & Peking Union Medical College · CN81th Hospital of PLA · CNJiangsu Provincial Center for Disease Control and Prevention · CNNanjing Medical University · CNSecond Military Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo describe the prevalence of modifiable risk factors for upper digestive tract cancer (UDTC) and its coprevalence, and investigate relevant influencing factors of modifiable UDTC risk factors coprevalence among residents aged 40-69 years in Yangzhong city, China.

designCross-sectional study.

participantsA total of 21 175 participants aged 40-69 years were enrolled in the study. 1962 subjects were excluded due to missing age, marital status or some other selected information. Eventually, 19 213 participants were available for the present analysis. MAIN OUTCOMES MEASURES: Prevalence and coprevalence of eight modifiable UDTC risk factors (overweight or obesity, current smoking, excessive alcohol consumption, insufficient vegetables intake, insufficient fruit intake and the consumption of pickled, fried and hot food) were analysed.

resultsThe prevalence of overweight/obesity, current smoking, excessive alcohol consumption, insufficient vegetables intake, insufficient fruit intake and the consumption of pickled, fried and hot food in this study was 45.3%, 24.1%, 16.2%, 66.1%, 94.5%, 68.1%, 36.0% and 88.4%, respectively. Nearly all (99.9%) participants showed one or more UDTC risk factors, 98.6% of the participants showed at least two risk factors, 92.2% of the participants had at least three risk factors and 69.7% of the participants had four or more risk factors. Multivariate logistic regression analysis revealed that men, younger age, single, higher education, higher annual family income and smaller household size were more likely to present modifiable UDTC risk factors coprevalence.

conclusionsThe prevalence and coprevalence of modifiable UDTC risk factors are high among participants in Yangzhong city. Extra attention must be paid to these groups who are susceptible to risk factors coprevalence during screening progress. Relative departments also need to make significant public health programmes that aim to decrease modifiable UDTC risk factors coprevalence among residents aged 40-69 years from high-risk areas of UDTC.

Indexed as

Gastrointestinal TractNeoplasmsAdultAgedChinaCitiesCross-Sectional StudiesHumansMaleMiddle AgedPrevalenceRisk Factorsendoscopyepidemiologyrisk management

Identifiers

PMID33827830
PMCPMC8031018
OpenAlexW3150702360

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.